Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00498498 · ClinicalTrials.gov registry record
Observational Endothelin and Markers of Cellular Apoptosis In CSF Head Injury
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 51
- Enrollment target
NCT00498498 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 51 participants.
The verdict
NCT00498498 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The goal of this study is to answer the following questions: * What is the time course of the expected changes in endothelin levels during the first two weeks after injury and how does this relate to outcome? * What is the relation between endothelin levels (big ET-1 and ET-1) in plasma and cerebrospinal fluid and type of injury, from CT scans and GCS? * What is the relation between endothelin levels (big ET-1 and ET-1) in plasma and cerebrospinal fluid and outcome measurements like GOSE, ICP and CT scans? * What is the relation between neurohormones related to the neutral endopeptidase (NEP) (ANP, BNP and cGMP) in plasma and cerebrospinal fluid and type of injury, from CT scans and GCS? * What is the relation between endothelin levels (big ET-1 and ET-1) in plasma and cerebrospinal fluid and markers for apoptosis?
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00498498
The ClinicalTrials.gov registry entry for NCT00498498 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00498498 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00498498 about?
NCT00498498 is a clinical study titled "Observational Endothelin and Markers of Cellular Apoptosis In CSF Head Injury". The goal of this study is to answer the following questions: * What is the time course of the expected changes in endothelin levels during the first two weeks after injury and how does this relate to outcome? * What is the relation between endothelin levels (big ET-1 and ET-1) in plasma and cerebro...
What is the current status of trial NCT00498498?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2007-07. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00498498?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.